| RS863224735 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863224738 |
RAD50
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863224741 |
RAD50
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863224747 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224748 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224749 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS863224752 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS863224753 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS863224754 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS863224756 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS863224758 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS863224759 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast cancer |
| RS863224760 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS863224763 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS863224764 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS863224765 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS863224766 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS863224769 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS863224772 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Inborn genetic diseases |
| RS863224774 |
GDAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS863224778 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS863224780 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Distal spinal muscular atrophy |
| RS863224781 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4C |
| RS863224782 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS863224783 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224786 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224787 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224788 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224789 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224792 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS863224800 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS863224801 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS863224802 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS863224804 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS863224806 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS863224807 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS863224809 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS863224810 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS863224817 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS863224820 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Carcinoma of colon |
| RS863224822 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS863224824 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS863224825 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS863224827 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS863224828 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS863224829 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS863224833 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS863224835 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS863224837 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS863224838 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS863224839 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS863224842 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS863224843 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS863224844 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Mitochondrial complex I deficiency |
| RS863224845 |
ACAD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Acyl-CoA dehydrogenase 9 deficiency |
| RS863224846 |
ACVR1
|
Health Risk |
Likely pathogenic |
Progressive myositis ossificans, Progressive myositis ossificans |
| RS863224847 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome |
| RS863224850 |
BCOR
|
Health Risk |
Likely pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS863224851 |
BRWD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 93 |
| RS863224852 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Spinocerebellar ataxia type 6 |
| RS863224853 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS863224854 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS863224855 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224856 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS863224857 |
CHD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS863224858 |
CLCNKB
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 3, Bartter disease type 4B |
| RS863224860 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS863224861 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS863224862 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS863224863 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 7, Retinal dystrophy |
| RS863224864 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS863224865 |
DCAF17
|
Health Risk |
Pathogenic |
Woodhouse-Sakati syndrome, Woodhouse-Sakati syndrome |
| RS863224868 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS863224869 |
ETFDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS863224870 |
FA2H
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 35, Hereditary spastic paraplegia 35 |
| RS863224871 |
FADD
|
Health Risk |
Pathogenic |
FADD-related immunodeficiency, FADD-related immunodeficiency |
| RS863224872 |
FGF23
|
Health Risk |
Likely pathogenic |
Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome, Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome |
| RS863224873 |
GARS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2D, Neuronopathy |
| RS863224874 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Deafness-lymphedema-leukemia syndrome |
| RS863224876 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudohypoparathyroidism, Pseudohypoparathyroidism type 1C |
| RS863224877 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Nonpapillary renal cell carcinoma |
| RS863224878 |
HSPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 13, Spastic paraplegia |
| RS863224879 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS863224880 |
IGHMBP2
|
Health Risk |
Pathogenic |
7 conditions, Autosomal recessive distal spinal muscular atrophy 1 |
| RS863224881 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS863224882 |
ITPR1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS863224883 |
KAT6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS863224884 |
KCNJ13
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 16, Leber congenital amaurosis |
| RS863224885 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS863224886 |
KDM6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 2, Medulloblastoma WNT activated |
| RS863224887 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS863224888 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS863224889 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS863224890 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS863224891 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS863224892 |
LIPT1
|
Health Risk |
Likely pathogenic |
Lipoyl transferase 1 deficiency, Lipoyl transferase 1 deficiency |
| RS863224894 |
MERTK
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS863224895 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS863224897 |
MTFMT
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 15, Combined oxidative phosphorylation defect type 15 |
| RS863224898 |
MMUT
|
Health Risk |
Pathogenic |
— |